ADDvise Group

ADDvise Group publishes its interim report October 1 – December 31, 2024 on Thursday, February 20, 2025 at 7.45 am (CET).

Media, investors and analysts are invited to attend a webcast and teleconference on the same day at 14:00 (CET). CEO, Staffan Torstensson, and Interim CFO, Johan Irwe, will present the report.

Webcast

If you wish to participate via webcast, please use the link below. Via the webcast you can ask written questions.

https://addvise-group.events.inderes.com/q4-report-2024/register

Conference call

If you wish to participate via teleconference, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.

https://conference.inderes.com/teleconference/?id=5004809

The report, presentation material and a link to the webcast will be available on
https://www.addvisegroup.com/investor-relations/

For further information, please contact:

Staffan Torstensson, CEO
+46 70 433 20 19
staffan.torstensson@addvisegroup.se

About ADDvise Group

ADDvise is an international life science group. Operating a decentralised ownership model, we develop and acquire high quality companies within the business areas Lab and Healthcare. The Group comprises more than 20 companies and generates annual revenues of close to SEK 1.7 billion. ADDvise is listed on Nasdaq First North Premier Growth Market. Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the company's Certified Adviser. More information is available at www.addvisegroup.com.